Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón Complutense University of Madrid, Madrid, Spain.
BMC Endocr Disord. 2014 Mar 14;14:25. doi: 10.1186/1472-6823-14-25.
To study hormonal changes associated with severe hyperglycemia in critically ill children and the relationship with prognosis and length of stay in intensive care.
Observational study in twenty-nine critically ill children with severe hyperglycemia defined as 2 blood glucose measurements greater than 180 mg/dL. Severity of illness was assessed using pediatric index of mortality (PIM2), pediatric risk of mortality (PRISM) score, and pediatric logistic organ dysfunction (PELOD) scales. Blood glucose, glycosuria, insulin, C-peptide, cortisol, corticotropin, insulinlike growth factor-1, growth hormone, thyrotropin, thyroxine, and treatment with insulin were recorded. β-cell function and insulin sensitivity and resistance were determined on the basis of the homeostatic model assessment (HOMA), using blood glucose and C-peptide levels.
The initial blood glucose level was 249 mg/dL and fell gradually to 125 mg/dL at 72 hours. Initial β-cell function (49.2%) and insulin sensitivity (13.2%) were low. At the time of diagnosis of hyperglycemia, 50% of the patients presented insulin resistance and β-cell dysfunction, 46% presented isolated insulin resistance, and 4% isolated β-cell dysfunction. β-cell function improved rapidly but insulin resistance persisted. Initial glycemia did not correlate with any other factor, and there was no relationship between glycemia and mortality. Patients who died had higher cortisol and growth hormone levels at diagnosis. Length of stay was correlated by univariate analysis, but not by multivariate analysis, with C-peptide and glycemic control at 24 hours, insulin resistance, and severity of illness scores.
Critically ill children with severe hyperglycemia initially present decreased β-cell function and insulin sensitivity. Nonsurvivors had higher cortisol and growth hormone levels and developed hyperglycemia later than survivors.
研究与危重病儿童重度高血糖相关的激素变化,以及与预后和重症监护病房住院时间的关系。
对 29 例重度高血糖的危重病儿童进行观察性研究,重度高血糖定义为 2 次血糖测量值均大于 180mg/dL。使用小儿死亡率指数(PIM2)、小儿死亡率风险评分(PRISM)和小儿逻辑器官功能障碍评分(PELOD)评估疾病严重程度。记录血糖、糖尿、胰岛素、C 肽、皮质醇、促肾上腺皮质激素、胰岛素样生长因子-1、生长激素、促甲状腺激素、甲状腺素和胰岛素治疗情况。根据稳态模型评估(HOMA),使用血糖和 C 肽水平,确定β细胞功能和胰岛素敏感性及抵抗性。
初始血糖水平为 249mg/dL,72 小时后逐渐降至 125mg/dL。初始β细胞功能(49.2%)和胰岛素敏感性(13.2%)较低。在诊断高血糖时,50%的患者存在胰岛素抵抗和β细胞功能障碍,46%的患者存在孤立性胰岛素抵抗,4%的患者存在孤立性β细胞功能障碍。β细胞功能迅速改善,但胰岛素抵抗持续存在。初始血糖与其他任何因素均不相关,血糖与死亡率之间也无关系。死亡患者在诊断时皮质醇和生长激素水平较高。住院时间与 C 肽和 24 小时血糖控制、胰岛素抵抗和疾病严重程度评分相关,但与单因素分析无关。
患有严重高血糖的危重病儿童最初表现为β细胞功能和胰岛素敏感性降低。非幸存者在诊断时皮质醇和生长激素水平较高,且比幸存者更晚发生高血糖。